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THE SHROOM FAMILY MEMBER, APXL, BINDS ACTIN AND LOCALIZES TO 
SITES OF CELL ADHESION 
Jennifer E. Phillips, M.S. 
University of Pittsburgh, 2006
The actin cytoskeleton is essential for a vast array of cellular processes and behaviors including 
migration, cell adhesion, intracellular trafficking, and maintenance of cell shape. Regulation of 
cytoskeletal dynamics is achieved through the actions of a diverse group actin-binding proteins. 
The actin-binding protein Apxl, is a member of the Shroom protein family, which also includes 
Apx and KIAA1202.  Shroom, the most well-characterized member of this family, binds and 
bundles actin stress fibers and is required for apical constriction of the neuroepithelium during 
neural tube closure in mice and Xenopus embryos.  Apxl was named for its similarity to Apical 
Protein Xenopus (Apx), a regulator of an amilioride-sensitive sodium channel. All Shrm family 
members possess at least two of three conserved domains; a N-terminal PDZ domain, a centrally 
located ASD1 (APX/Shroom Domain) and a C-terminal ASD2 domain. Because of its similarity 
to Shroom, mouse Apxl was sequenced and cloned in order to begin initial characterization of 
the protein. Western blot analysis has shown that mAxpl is expressed in the majority of adult 
tissues. Immunofluorescence analysis of frozen sections has demonstrated that Apxl is 
specifically expressed in multiple populations of polarized cells, such as the neuroepithelium, 
vascular endothelium, and the epithelium of renal tubules. The subcellular localization of Apxl 
was investigated and Apxl was found to reside at the plasma membrane of non-adherent cells 
and in the apical compartment of polarized cells, possibly through interactions with cortical actin 
or members of the apical junctional complex. Analysis of Apxl deletion proteins has revealed 
that the ASD1 domain is crucial for proper localization, while the requirement for the PDZ 
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domain varies in different cell lines. Cytochalasin D treatment of Rat1 fibroblasts has indicated 
that disruption of the actin cytoskeleton perturbs Apxl localization. Additionally, Apxl directly 
binds actin through its ASD1 domain in F-actin cosedimentation experiments. Apxl is expressed 
in multiple polarized cell types where it binds cortical actin and localizes to the apical junctional 
complex. Although the biological function of Apxl is unknown, its expression pattern, 
subcellular localization, and similarity to Shroom suggest that Apxl plays a role in regulation of 
cellular architecture throughout development.   
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1.0  INTRODUCTION 
1.1 ACTIN-BINDING PROTEINS AND CELL BEHAVIOR 
The complex process of cell and tissue movements that culminate in a highly organized embryo 
is one of the most fascinating aspects of developmental biology. These dramatic morphogenetic 
movements are crucially dependent upon the actin cytoskeleton. Indeed, eukaryotic cells depend 
upon their actin cytoskeleton for a wide array of processes and behaviors. The actin cytoskeleton 
is essential for activities such as migration, cell division, cell/cell and cell/substratum adhesion, 
and intracellular trafficking [1-7].  Additionally, the development, maintenance, and alteration of 
cell structure and shape are dependent upon the actin cytoskeleton. Regulation of cytoskeletal 
dynamics is controlled by a diverse group of proteins referred to as actin-binding proteins 
(ABPs). Several different classes of ABPs exist that regulate functions such as G-actin 
sequestration, actin assembly/disassembly, filament severing or capping, crosslinking, and 
bundling proteins. Other known ABPs function as adaptor proteins to link actin to other 
cytoskeletal elements or to the plasma membrane [3, 5, 8].  
Cellular motility is dependent upon biomechanical forces generated by the actin 
cytoskeleton and associated proteins [4, 9, 10]. Migration can be visualized as a cyclical process. 
In the first step, actin-polymerization drives the extension of a wide, sheet-like lamellipodium or 
a narrow, finger-shaped filopodium [4, 10].  The extended cellular protrusion anchors the cell to 
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the extracellular matrix via focal contacts. Subsequently, contraction of actomyosin  filaments 
provides the traction force required to pull the cell forward and to induce disassembly of focal 
contacts at the rear of the cell [2, 10].  ABPs play a role in cell migration by regulating the 
architecture of the protrusion. N-WASP proteins and the Arp2/3 complex are known to regulate 
lamellipodium formation by nucleating new actin filaments. Similarly, Ena/VASP family 
proteins play a role in regulating the growth of filopodia. Numerous other ABPs determine the 
rate of actin polymerization, and hence influence the rate of migration, by regulating the 
availability of G-actin monomers and free ends [2, 4, 5]. For example, ADF/cofilin family 
proteins enhance the pool of actin monomers by promoting filament severing and disassociation.   
The actin cytoskeleton and associated ABPs are also intimately involved in the 
establishment, maintenance and rearrangement of cell-cell and cell-matrix adhesions. Indeed, 
cell contacts such as focal adhesions or adherens junctions (AJ) function to link the actin 
cytoskeleton to the extracellular matrix or to the cytoskeleton of neighboring cells.  Formation of 
cell adhesions and organization of the actin cytoskeleton are interdependent processes. For 
example, disruption of the Drosophila  Armadillo, a homolog of vertebrate β-catenin, leads to 
widespread polarity defects in the actin cytoskeleton [1]. Conversely, depolymerization of 
cortical actin disrupts AJs [11].  However, the role of the actin cytoskeleton in AJ formation is 
not simply to act as a scaffold to cluster cadherins at the plasma membrane. Although cadherin 
proteins bind preformed actin filaments, interactions between cadherins and the Arp2/3 complex 
play a role in the establishment of AJs by regulating actin polymerization at sites of cell-cell 
contact [12, 13].   
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1.2 CELL POLARITY AND INTERCELLULAR ADHESIONS 
Apical-Basal polarity is a fundamental aspect of epithelial cells and is an essential 
requirement for many of their processes and functions, including vectorial transport, signal 
transduction, cell adhesion, and barrier formation. Polarized cells are generally understood as 
possessing three membrane domains, the apical, lateral, and basal. Tight junctions (TJ) form the 
most apical component of the junctional complex and define the border between the apical and 
lateral membranes (Fig. 1).  Tight junctions function mechanically as a barrier to epithelial 
permeability and as a fence to restrict the movement of membrane proteins and lipids between 
the apical and basal/lateral compartments [14].  Occludin, claudins, and junctional adhesion 
molecule (JAM) constitute the integral membrane proteins of the tight junctions [15-17]. 
Numerous accessory and regulatory proteins localize to the cytoplasmic plaque of tight 
junctions, such as ZO-1, -2, and -3, and Cingulin (Fig. 1). 
The lateral membrane is defined by cell-cell adhesion complexes, such as adherens 
junctions and hemidesmosomes. AJs created cell-cell contacts through the homophilic binding of 
cadherins and link to the actin cytoskeleton through accessory proteins such as α− and β−catenin 
and vinculin/α-actinin (Fig. 1). Not only do AJs help to provide structural integrity for the cell, 
recent evidence suggests that cell-cell contacts are a crucial event in developing apical-basal 
polarity [18, 19]. Within the basal membrane cells are anchored to the extracellular matrix by 
focal adhesions and hemidesmosomes. These basal junctions provide mechanical strength by 
linking integrins to intermediate filaments at hemidesmosomes and to actin at focal adhesions. 
 Endothelial cells constitute another example of polarized cells and possess similar 
junctional organization. Both endothelial and epithelial cell types utilize adherens junctions and 
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tight junctions to join cells together. Major differences between these cell types include the 
absence of hemidesmosomes in endothelial cells [20-22]. Additionally, endothelial junctions are 
not as well organized and adherens junctions and tight junctions are often intermingled within 
the lateral membrane [20-22].  
 
Figure 1: Components of the intercellular junctional complex  
(A) Schematic of a typical mammalian epithelial cell with distinct apical and basolateral membrane domains, as well 
as specialized adhesion complexes such as tight junctions, adherens junctions, desmosomes and hemidesmosomes 
(IF = Intermediate filaments). (B) An enlarged view of the junctional complex highlighting some of the key 
components of tight junctions and adherens junctions. 
 
1.3 THE SHROOM PROTEIN FAMILY 
Shroom (Shrm) is an F-actin binding protein which is required for proper neural tube closure in 
mice and frogs [23, 24]. Shrm-deficient embryos display both exencephaly and spina bifida [23, 
24]. Sequence analysis has revealed that Shrm is a member of a larger gene family which 
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includes the vertebrate proteins apx (Apical Protein Xenopus), APXL (Apical Protein Xenopus-
Like), and hKIAA1202. All Shrm family members possess at least two of three conserved 
domains; an N-terminal PDZ domain, a centrally located ASD1 (APX/Shroom Domain) and a C-
terminal ASD2 domain (Fig.2). PDZ (PSD95/DLG/ZO-1) domains are conserved protein-protein 
interaction domains which appear to be important for organizing protein complexes at the plasma 
membrane [25]. The ASD domains are novel domains with no previously determined function. 
Previous work has shown that the Shrm ASD1 is required for F-actin binding and proper 
subcellular localization. The ASD2 domain of Shrm has been shown to be necessary and, under 
specific conditions, sufficient to induce apical constriction [23]  
Human APXL was identified because of its association with the X-linked ocular albinism 
[26]. Although APXL lies in close proximity to the OA1 gene on the X-chromosome, no 
evidence supports a direct role in ocular albinism. Apxl was named for its similarity to Apical 
Protein Xenopus (Apx). Apx was identified by expression cloning using an antibody to the apical 
surface of Xenopus epithelial cells [27, 28]. Apx is believed to be a regulator of ENaC, an 
amilioride-sensitive sodium channel that plays an important role in kidney function [28, 29].  
The similarity between Apxl and Shrm raises the possibility that Apxl functions in neural 
tube closure or the regulation of cellular architecture. The mouse homolog of Apxl was cloned 
and sequenced, in order to begin characterization of the protein. Sequence analysis indicates that, 
like Shrm, Apxl possesses an N-terminal PDZ domain, a centrally located ASD1 domain and a 
C-terminal ASD2 domain. Apxl is 35% identical to Shroom over the length of the protein, with 
much higher identity in the PDZ, ASD1, and ASD2 domains (64%, 52%, and 60%, respectively) 
[30]. 
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KIAA1202 possesses both an N-terminal PDZ domain and a C-terminal ASD2 domain.  
Like other Shrm family members, mKiaa1202 is expressed widely in mouse embryonic and adult 
tissues ([31] and Yoder, unpublished data). Despite lacking the actin-binding ASD1 domain, 
K1202 localizes to actin-rich structures in the cytoplasm ([30, 31]. When the actin 
polymerization inhibitor latrunculin B is used to disrupt the actin cytoskeleton of HeLa cells, 
KIAA1202 remains associated with F-actin remnants.  Although no known function of 
KIAA1202 has been determined, an association between KIAA1202 and X-linked mental 
retardation has recently been discovered [31].  
Additionally, several putative invertebrate Shrm orthologs have been identified in 
Drosophila, Ciona intestinalis (sea squirt), and Strongylocentrotus purpuratus (sea urchin). The 
Drosophila ortholog, CG8603, possesses an ADS2 domain but lacks the PDZ or ASD1 domains. 
CG8603 over-expression has been reported to extend the longevity of flies [32]. Recent research 
has shown that CG8603 localizes to the cortical actin cytoskeleton in Rat1 fibroblasts and Shrm-
CG8603 chimeras possessing the CG8603 ASD2 domain are capable of inducing apical 
constriction in MDCK cells [30]. Analysis of Ciona (CiGC24a06)  and sea urchin (GenBank 
accession XM-778480) genomes has revealed putative Shrm orthologs  which possess both the 
PDZ and ASD2 domains [30, 32].   
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Figure 2: The Shroom protein family 
The vertebrate members of the Shrm gene family include Shrm, Apxl, Apx and KIAA1202. Family 
members possess at least one of three conserved domains. The invertebrate family members are not 
pictured here. 
 
 
1.4 NEURAL TUBE DEFECTS AND NEURAL TUBE CLOSURE 
Neural tube defects (NTDs) are a fairly common type of birth defect, affecting approximately 1 
out of every 1000 live births [23, 33-36]. Failure of the neural tube to close properly results in 
serious birth defects such as anencephaly and spina bifida.  Causes for NTDs are complex and 
multifactorial, involving both environmental and genetic influences. Although research has 
shown that a significant number of NTDs can be prevented by folic acid supplementation during 
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pregnancy, approximately 30% of NTDs remain resistant to folate supplementation [23, 37].  
Misregulation of or mutations in numerous genes may result in NTDs and few single genetic 
defects are known to cause NTDs in humans. Over 80 mouse models for NTDs exist and indicate 
the importance of processes and pathways such as Shh signaling, convergent extension, apical 
constriction, and planar cell polarity in neural tube closure [23, 34, 35, 38-41]. Despite the 
clinical importance of neural tube closure, many of the molecular mechanisms regulating this 
morphogenetic process are still poorly understood.   
Closure of the neural tube is a morphogenetic process in which a sheet of polarized 
epithelium, the neural plate, undergoes a series of morphogenetic movements driven by both 
internal and external forces. Briefly, neural tube closure occurs in three steps: the elevation of the 
neural plate, bending of the neural folds, and finally, fusion of the folds to form the neural tube 
[33, 42]. Once the neural plate has formed, it elongates along the rostral-caudal axis by 
convergent extension.  Failure of planar cell polarity signaling and convergent extension leads to 
NTDs, presumably because the neural folds remain too far apart to appose and fuse [41, 43]. 
After elongation, the lateral borders of the neural plate elevate due, in part, to proliferative forces 
arising from underlying mesoderm [44].  Extrinsic forces, such as pushing forces generated by 
the surface ectoderm, also contribute to elevation of the neural folds [33, 42, 43]. Following 
elevation, bending of the neural folds occurs at specific sites referred to as hingepoints. A medial 
hingepoint (MHP) forms above the notochord, and two dorsolateral hingepoints (DLHP) form on 
the lateral edges of the neural folds (Fig 3). This rotation of the neural folds around the 
hingepoints allows their juxtaposition at the dorsal midline and fusion. Once the neural folds 
have fused to form a closed cylinder, differential expression of cell adhesion molecules cause the 
neural tube to separate from the surface ectoderm [45, 46].   
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Figure 3: Morphogenetic movements during neural tube closure 
During neurulation, the neural plate must transform from a flat sheet (A) to a closed tube (D). (B) The 
process of neural tube closure begins with the elevation of the neural plate (NP). Apical constriction of 
cells within the medial (MHP) and dorsal lateral hingepoints (DLHP) drives the bending and rotation of the 
neural folds (C). In the final steps of neural tube closure the neural folds meet at the midline and fuse, and 
the neural tube (NT) separates from the surface ectoderm (SE) (D).  
 
 
Formation of the hingepoints requires cells to undergo dramatic cytoskeletal and cell 
shape changes, transforming from a columnar shape to a wedge-shape. This change in cellular 
morphology is believed to occur primarily through the process of apical constriction. During the 
process of apical constriction, a dense apical actin-myosin belt contracts, resulting in a reduction 
of the apical surface area relative to the basal surface area (Fig. 4). Because cells of an epithelial 
sheet are connected to one another by numerous cell adhesions, this reduction in apical surface 
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area relative to basal surface area would create a pulling force that could drive bending of the 
neural epithelium.  
 
 
Figure 4: The purse-string model of apical constriction 
According to the purse-string model of apical constriction, contraction of the apical actin-myosin band 
causes the apical surface of the cell to shrink, transforming the cell from a columnar shape to a wedge-
shape. 
 
Bending of epithelial sheets is required for the morphogenesis of multiple structures in 
numerous organisms including ventral furrow formation in Drosophila, C. elegans gastrulation, 
and optic vesicle formation in vertebrates [47-51]. Apical constriction is known to provide at 
least some of the mechanical force required for epithelial sheet bending during many of these 
processes. However, very little is known about the how apical constriction in the vertebrate 
neural epithelium is regulated on the cellular or molecular level.  
Additionally, a slowing of the rate of cell division in the hingepoints has been suggested 
to play a role in cell shape change. In a process known as interkinetic nuclear migration, the 
nuclei of dividing cells travel between the basal and apical poles [42, 44, 52]. A slowing of the 
cell cycle in hingepoint cells requires the nuclei to remain basal, thus contributing to the basal 
expansion that accompanies apical constriction [33, 42]. Extrinsic forces involved in neural tube 
closure include pushing forces generated by the directed mitosis, cell flattening, and intercalation 
of non-neural ectoderm [33, 42, 49, 53].  
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Once the neural folds converge at the midline, they undergo fusion. Research in mice has 
identified three distinct closure points [54]. The first point of closure occurs at the 
hindbrain/cervical boundary, at approximately embryonic day (e) 8.5 in the mouse. From this 
first fusion point, neural tube closure proceeds both rostrally and caudally, in a zipper-like 
fashion.  A second closure takes place at the forebrain/midbrain boundary, and closure continues 
bidirectionally. A final de novo closure takes place at the rostral extremity of the forebrain. 
1.5 THE ROLE OF SHROOM IN NEURAL TUBE CLOSURE 
Shrm is required for apical constriction during neural tube closure in mice and Xenopus [23, 24]. 
Homozygous Shrm mutant mice exhibit a variety of neural tube defects, including exencephaly, 
acrania, facial clefting, and spina bifida. Inactivation of Shrm in Xenopus embryos by 
morpholino knockdown or by expression of a dominant-negative form of Shrm inhibits apical 
constriction and leads to a failure of cranial neural tube closure [23]. Shrm localizes to the stress 
fibers of fibroblast cell lines and to the apical region of adherens junctions in polarized epithelial 
lines [24]. Within the neural epithelium of e9.25 mouse embryos, Shrm is restricted to the apical 
junctional complex.  This localization is consistent with the hypothesis that Shrm directs neural 
tube closure by inducing constriction of the apical actin belt of neural epithelium. 
Since its initial characterization, research has revealed that Shrm can induce naïve 
Xenopus epithelium as well as confluent monolayers of MDCK cells to accumulate apical actin 
and to constrict their apical surface [23]. Failure of apical constriction in Shrm mutants leads to 
defects in hingepoint formation and epithelial sheet bending, resulting in the observed NTDs. 
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Recent work has shown that Shrm’s ability to induce apical constriction and elicit changes in cell 
shape require the activity of non-muscle myosin II [39].  
 
1.6 THESIS OVERVIEW 
Actin binding proteins are involved in a diverse collection of cell processes and behaviors, 
including migration, cell adhesion, morphogenesis, and vesicular trafficking. The goal of my 
research has been to investigate the cellular function of a novel actin-binding protein, Apxl. In 
this thesis, I describe the work I have done in order to provide an initial characterization of Apxl.  
I have explored the expression pattern of Apxl in adult and embryonic mouse tissues as well as 
the subcellular localization of Apxl. Analysis of a series of Apxl truncations has helped to 
elucidate the contribution of each of the three conserved domains to Shrm protein family 
function.  Additionally I have determined that Apxl is capable of binding F-actin through its 
ASD1 domain. Although no known function exists for Apxl, its expression pattern and its 
relationship to Shrm suggest that it may play a role in regulation of cellular architecture 
throughout development.   
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2.0  MATERIALS AND METHODS 
2.1 CELL CULTURE 
Rat1 fibroblast and CtBP90 cell lines were maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% fetal bovine serum (FBS), penicillin/streptomycin, and L-glutamine. MDCK 
cells were maintained in Eagle’s Minimum Essential Media (EMEM) supplemented with 10% 
FBS, penicillin/streptomycin, and L-glutamine.  All cell lines were cultured at 37 o C and 5% 
CO2.  For expression of exogenous Apxl, cells were transfected using 1-2 μg of DNA and 
Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer’s 
recommendations. 
2.2 MOLECULAR BIOLOGY 
To create the series of Apxl deletion constructs, portions of Apxl cDNA encoding amino acids 1-
513, 1-880, 513-880, 880-1479, and 1-1479 (full-length Apxl) were cloned into the pCS3mt 
expression vector in frame with the 6X Myc tag. Cloning of Apxl deletion constructs was 
performed by Teresa Bernaciak and Jennifer Phillips. 
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2.3 ANTIBODIES, WESTERN BLOTTING AND IMMUNOFLUORESENCE 
Apxl-specific sera was generated by Cocalico Biologicals by injecting rabbits with Glutathione 
S-transferase-tagged Apxl 878-1287 (GST-Apxl 878-1287).  Apxl-specific antibodies were 
affinity purified using GST-Apxl 878-1287 coupled to Sepharose. 
For western blotting, cells were lysed on ice in 0.4 mL RIPA buffer (150mM NaCl, 1.0% 
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and 50mM Tris pH8.0) with 1mM  
phenylmethylsulfonyl fluoride (PMSF) and Aprotinin, centrifuged at 13,000 x g, and mixed with 
an equal volume of 2X Laemmeli sample buffer. Embryo and tissue lysates were generated by 
homogenizing samples in RIPA buffer plus protease inhibitors at 4o C with a tissue tearor and 
mixed with Laemmli sample buffer. All lysates were heated to 100o C for five minutes prior to 
separation by SDS-PAGE and total proteins were transferred to nitrocellulose membranes. Blots 
were blocked in 4% dehydrated non-fat milk in Tris-Buffered Saline Tween 20 (TBST) for 1 
hour at room temperature. Apxl was detected by incubating blots with anti-Apxl (1:100 dilution 
in 4% milk/TBST) or mouse monoclonal antibody (mAb) 9E10 (anti-myc, 1:200 dilution in 4% 
milk/TBST) at 4o C overnight. Blots were washed 3 times for 5 minutes in TBST prior to 
addition of secondary antibody. Primary antibodies were detected by incubation with goat anti-
rabbit or goat anti-mouse horseradish peroxidase-conjugated secondary antibody (1:2500 in 
TBST, Amersham) for 1 hour at room temperature, followed by 3 5 minute washes in TBST. 
HRP-conjugated secondary antibodies were visualized using enhanced chemiluminescence 
reagents (Amersham).  
Prior to immunofluorescent staining, cells were grown on glass coverslips and then fixed 
in -20o C methanol for 5 minutes or 4% paraformaldehyde in phosphate buffered saline (PBS) 
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for 15 minutes and washed with PBS. Indirect immunofluorescence was performed with affinity-
purified anti-Apxl (1:50), rat anti-CD31/PECAM-1 (BD Pharmingen, 1:400), anti-
Neurofilament, Rat anti-ZO-1 (1:200, Chemicon), anti-E-cadherin (1:400, BD Pharmingen), 
mAb anti-β-catenin (1:200, BD Pharmingen), and anti-Myc mAB 9E10. All primary antibodies 
used for immunofluorescence were diluted in PBS/0.1% Tween 20 (PBT). Primary antibodies 
were visualized using Alexa-488 and -568 conjugated secondary antibodies (1:400, Molecular 
probes). F-actin was detected with Tetramethylrhodamine B isothiocyanate (TRITC) or Alexa-
633 conjugated phalloidin (Sigma and Molecular Probes, respectively).  
To generate frozen sections used for immunocytochemistry, embryos or adult tissues 
were isolated and incubated in 4% paraformaldehyde at 4o C for 1-3 hours. Embryos or tissues 
were then washed in cold PBS, and incubated in 30% sucrose overnight at 4o C.  Samples were 
embedded in OCT and 10-12 μΜ sections were cut at -20o C using a Leica cryostat. Prior to 
staining, sections were rehydrated in PBS for 5 minutes at room temperature and blocked in 1% 
goat serum in PBT for 30 minutes at room temperature. Sections were incubated with primary 
antibody in 1% goat serum/PBT at room temperature for 2-3 hours or overnight at 4o C and 
washed 3 times in PBT at room temperature.  Sections were incubated in secondary antibody 
diluted in 1% goat serum/PBT for 1-2 hours in the dark at room temperature, then washed in 
PBT. Slides were mounted using Vectashield mounting medium (Vector Labs).   Images were 
collected using a Biorad Radiance 2000 Laser Scanning System and a Nikon E800 microscope 
and processed using Adobe Photoshop. 
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2.4 CO-IMMUNOPRECIPITATION  
To perform co-immunoprecipitation experiments, whole embryo lysates were generated by 
homogenizing e10.5 mouse embryos in RIPA buffer plus protease inhibitors with a Dounce 
homogenizer at 4o C. Apxl was precipitated from 1 mL of whole embryo lysates by incubation 
with 50 μl anti-Apxl and 50 μl protein A sepharose beads (Amersham) for 1 hour at 4oC with 
constant rocking.  Immune complexes were washed in RIPA buffer to remove unbound proteins 
and resuspended in Laemmeli sample buffer. Beads were heated to 100oC to uncouple 
immunoprecipitated proteins from the beads, and proteins were separated by SDS-PAGE and 
transferred to nitrocellulose membranes.  Blots were probed with anti-Apxl (1:250), Rat anti-ZO-
1 (1:400, Chemicon), anti-Occludin (1:200, Santa Cruz), mAb anti-β-catenin (1:400, BD 
Pharmingin), and anti-Vinculin (1:200, Sigma) diluted in TBST+ 4% milk. 
2.5 ACTIN BINDING 
In order to perform the actin cosedimentation experiment, a GST-Apxl513-880 fusion protein 
was expressed in BL21 E. Coli and purified using glutathione-sepharose. F-actin was prepared 
by polymerization of G-actin (Cytoskeleton). For cosedimentation assays, GST-Apxl513-880 
was incubated for 1 hour at room temperature in the presence or absence of 0.08 μM 
polymerized F-actin. F-actin was pelleted by centrifugation at 100,000 x g in an airfuge and 
pellet and supernatant fractions were collected. Proteins were separated by SDS-PAGE and 
visualized with Coomassie blue.  
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3.0  EXPRESSION PROFILE OF APXL 
3.1 RESULTS 
Initial characterization of Apxl began with a survey of its expression pattern in mice. In order to 
determine when and where Apxl is expressed, a polyclonal antibody to amino acids 878 to 1287 
was generated and used for Western blot analysis and indirect immunofluorescence.  Anti-Apxl 
antibodies, but not pre-immune antibodies, detect a protein of approximately 210 kDa in both 
whole embryo lysates and immunoprecipitations from e10.5 mice. Although the predicted 
molecular mass for Apxl is 165 kDa, a molecular mass of 210 kDa is consistent with the 
observed molecular mass of other Shrm family members [24, 55]. Protein lysates were made 
from a variety of adult tissues, and Western blots were probed with Anti-Apxl (Fig. 5).  Apxl 
was detected in the majority of tissues tested, including the brain, lung, stomach and heart.  To 
further characterize Apxl in adult and embryonic mice, indirect immunofluorescence was 
performed on frozen sections using the Anti-Apxl antibody.  
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 Figure 5: Apxl is widely expressed in adult tissue lysates 
Lysates of numerous adult mouse tissues were analyzed by immunoblotting (A). An approximately 210 
kDa band corresponding to Apxl  was detected in lung, brain, eye, heart, thymus, and testis lysates. (B) 
Blots were probed with an anti-Vinculin antibody as a loading control. The approximately 116 kDa 
Vinculin band was observed in all lanes (arrow). 
 
Mouse embryos of various ages were cyrosectioned and stained to detect Apxl. In e10.5 
embryos Apxl expression can be detected in the cranial neural tube (Fig. 6A and 6B). Like Shrm, 
Apxl colocalizes with cortical actin in the apical portion of neuroepithelial cells (Fig. 6B). 
Detectable levels of Apxl expression were consistently observed in structures that resembled the 
embryonic vasculature. In order to verify this, sections were stained to detect Apxl and platelet 
endothelial cell adhesion molecule-1 (PECAM-1). PECAM-1 is a member of the 
immunoglobulin family of cell adhesion molecules. Because PECAM-1 is expressed in the 
vascular system in both developing and adult organisms, it is commonly used as an endothelial 
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cell marker [56-59]. Figure 6A shows Apxl colocalizing with PECAM-1 in blood vessels. In 
addition to its function as an adhesion molecule, PECAM-1 has also been identified as a scaffold 
for signaling and adaptor proteins [56-59]. Similar co-localization of Apxl and PECAM-1 in 
embryonic vasculature was observed throughout the embryo.  Expression of Apxl within the 
vasculature likely explains the broad distribution of Apxl positive tissue lysates detected by 
Western blot.  
Apxl is also expressed in the dorsal root ganglia (Fig. 6). Figures 6C and 6D show that at 
e10.5 and e12.5, respectively, Apxl expression is limited to the PECAM-positive vasculature 
surrounding the dorsal root ganglia.  By e15, however, cells of the dorsal root ganglia expressing 
the neuron marker Neurofilament (NF) have begun to express Apxl. 
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Figure 6: Apxl localizes to the apical surface of neural epithelium and to dorsal root ganglia 
  (A) Sections through an e10.5 neural tube were stained for Apxl (green), PECAM (red), and F-Actin (phalloidin, blue). 
Apxl colocalizes with actin at the apical surface of the neural epithelium (arrows), as well as with PECAM in the 
vasculature of the neural tube (arrowheads). (B) A magnified view of Apxl and Actin staining within the 
neuroepithelium of an e16.5 mouse. Apxl also appears to localize to differentiated neurons at this stage (arrows in B).  At 
e15 Apxl is express in NF-positive cells of the dorsal root ganglia (D), but not at e10.5. 
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Although Apxl expression was not detected in Western blots of adult kidney and 
intestinal lysates, specific expression was detected by immunostaining of these tissues (Fig. 7, 8). 
Apxl expression was detected within the apical membrane of renal and intestinal epithelial cells. 
Frozen adult kidneys were sectioned and stained for Apxl, ZO-1 and Actin. Specific expression 
was detected in the apical membrane of a subset of renal tubules, which may explain the inability 
to detect a strong Apxl band in Western blots (Fig. 7). Within the collecting ducts Apxl co-
localized with actin and displayed partial overlap with ZO-1. No co-localization was observed 
between Apxl and the adherens junction protein, β-catenin (Fig. 7B). 
 
 
Figure 7: Apxl is expressed in renal collecting ducts 
Sections of adult kidney stained for Apxl show localization to the apical surface of the renal collecting duct 
(A, B). Within renal tubules Apxl colocalizes with Z0-1 and actin (A), but not β-catenin, (yellow 
arrowheads in B).  
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Apxl also localized to the apical surface of intestinal epithelial cells. Frozen sections of 
adult intestine were sectioned and stained for Apxl, β-catenin, and PECAM. Figures 8A and 8B 
show Apxl localizing to the apical membrane of intestinal cells and not to the β-catenin positive 
lateral membranes. Although Apxl localizes to the embryonic vasculature, no co-localization is 
detected between Apxl and the endothelial cell marker, PECAM, in adult intestine.  
 
 
 
β-cat  Apxl β-cat  Apxl β-cat  Apxl 
 
Figure 8: Apxl is expressed in adult intestine 
(A, B) Apxl localizes to the apical membrane in cells of the adult mouse intestine (Apxl in green, β−catenin in 
red). (C) Apxl is not expressed in the vasculature of the adult intestine, as shown by a lack of colocalization 
with PECAM (red) 
 
3.2 DISCUSSION 
Western blot and immunofluorescence analysis reveal that Apxl is expressed in numerous tissues 
throughout the developing mouse, including the neural epithelium, vasculature, kidney, and 
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intestine. Apxl seems to be specifically expressed in polarized epithelial or endothelial cell types, 
where it resides at or near the apical membrane and junctional complexes.  
Regions of Apxl expression show a high degree of overlap with Shrm’s expression 
pattern, suggesting the possibility that Shrm and Apxl may function in some of the same 
morphogenetic and cellular processes.  Within the neural epithelium, Shrm and Apxl both 
colocalize with ZO-1 and actin at the apical border of the lateral membrane. Shrm and Apxl also 
localize similarly in renal tubules.     
Apxl expression in the kidney is particularly interesting in light of Apxl’s relation to Apx.  
Apx forms a complex with the renal epithelial sodium channel, ENaC, and α-spectrin. ENaC 
constitutes the main mechanism for NA+ absorption in the connecting tubule as well as other 
aldosterone-responsive transporting epithelia such as the colon and fetal lung [29, 60]. Sucrose 
density gradient centrifugation and immunoblot analysis from Xenopus A6 cells indicate that in 
ENaC, Apx, and α-spectrin are associated in a macromolecular complex, suggesting that Apx is 
required for the functional expression of ENaC in Xenopus epithelia [28]. In support of this 
hypothesis, Xenopus oocytes coinjected with ENAC cRNA and Apx antisense oligonucleotides 
showed a marked reduction in amiloride-sensitive current compared to oocytes coinjected with 
Apx sense oligonucleotides [28].  However, although Apx is believed to regulate ENaC 
conductance in Xenopus kidneys, the relationship between Apxl and ENaC, if any, remains 
undetermined.  
Transport across epithelial and endothelial barriers occurs through transcellular or 
paracellular pathways. Within the kidney, renal absorption and paracellular permeability are 
controlled, in part, by alterations in tight junction permeability. Paracellular transport through 
absorptive epithelia, such as the kidney and small intestine, is mediated largely by tight junction 
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composition. Claudin proteins exhibit distinct tissue expression patterns and this differential 
expression helps to regulate the permeability of tight junctions [17, 61, 62]. Studies of 
paracellular permeability frequently utilize Madin-Darby Canine Kidney (MDCK) cells as a 
model of barrier epithelia. Type I MDCK cells resemble cells of the distal collecting ducts and 
exhibit high electrical resistance, whereas type II MDCK cells are considered to be 
representative of the proximal tubule and display low electrical resistance [63-65].   Expression 
of claudin-2 in type I MDCK cells that normally express claudin-1 and -4 decreased 
transepithelial electrical resistance (TER) and increased paracellular permeability [17]. 
Conversely, over-expression of claudin-1 in MDCK cells dramatically increased TER and 
reduced paracellular permeability [66]. 
 Apxl localizes to the apical membrane of renal tubules, where it shows some degree of 
overlap with the tight junction marker ZO-1. Additionally, Apxl localizes to the apical surface of 
intestinal epithelia. Furthermore, Apxl is highly expressed in the vascular endothelium, another 
structure where paracellular permeability is tightly regulated. This expression pattern and 
subcellular localization suggests the possibility that Apxl is involved in regulation of paracellular 
transport in the mammalian kidney and intestine.  Attempts to observe the co-localization of 
Apxl with various claudins were inconclusive due to a lack of good antibodies. Much work 
remains to be done to elucidate the role, if any, Apxl plays in Na+ absorption or paracellular 
permeability. 
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4.0  APXL LOCALIZES TO SITES OF CELL ADHESION 
4.1 RESULTS 
4.1.1 Immunoprecipitation and Immunofluorescence 
Initial surveys of Apxl expression in embryonic mice suggested that like Shrm, Apxl was 
expressed primarily in polarized epithelial cells. More specifically, Apxl frequently localized to 
the cell membrane. Primary mouse cells were cultured and stained for endogenous Apxl in order 
to explore the subcellular localization of Apxl. Results from these initial experiments show that 
within these cells Apxl resides at the plasma membrane where it colocalizes with AJ proteins 
such as β-catenin and with the TJ marker, ZO-1 (Fig. 9). While Apxl costains with the adherens 
junction protein E-cadherin, Apxl displays a much more specific co-localization with ZO-1 in 
polarized cells.  
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Figure 9: Apxl localizes to cell adhesions 
Primary mouse embryos were cultured and stained for Apxl, ZO-1, and E-Cadherin.   Apxl localizes 
to sites of cell adhesion with both E-Cadherin (A) and ZO-1 (B).  
 
To further investigate the localization of Apxl in a polarized epithelial cell line, MDCK 
cells were utilized as a model cell line. MDCK cells transiently transfected with an epitope-
tagged version of the protein were grown on glass coverslips and stained for Apxl and ZO-1 
(Fig. 10). Although a large portion of Apxl remained cytoplasmic, a significant population of 
Apxl was observed at ZO-1-positive TJs (Fig. 10B, arrow). Apxl was not observed in the lateral 
membranes of transfected cells, suggesting that Apxl is specifically recruited to TJs or to other 
components of the apical junctional complex.  
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 Figure 10: Apxl localizes to tight junctions in MDCK cells 
Within a monolayer of MDCK cells, a portion of Apxl localizes to ZO-1-positive tight junctions (A and 
arrows in B). Only partial co-localization is observed, as a significant portion of Apxl remains cytoplasmic 
(A). 
 
  To determine how Apxl is recruited to sites of cell-cell adhesion, a series of co-
immunoprecipitation (Co-IP) experiments were performed. Because Apxl is frequently observed 
colocalizing with junctional proteins such as β-catenin and ZO-1, I hypothesized that Apxl might 
be in a complex with one or more junctional proteins. Apxl was immunoprecipitated from whole 
embryo lysates using the Apxl antibody. Co-IPs were analyzed by Western blot and blots were 
probed with antibodies to several cell adhesion proteins (Fig 11). Apxl was successfully 
immunoprecipitated from embryo lysates (Fig. 11E). Despite the presence of Apxl at tight 
junctions no interaction was detected between Apxl and the TJ proteins ZO-1 or Occludin (Fig 
10 B, D). Additionally, no interaction was detected between Apxl and β-catenin or the focal 
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adhesion/adherens junction protein, Vinculin (Fig. 11 A, C).  These results suggest that Apxl 
does not directly bind to these junctional proteins. Alternatively, large protein complexes may 
have been disrupted by the co-immunoprecipitation protocol. 
 
Figure 11: Apxl co-immunoprecipitation experiments 
Apxl was immunoprecipitated from whole embryo lysates and blots were probed with β-catenin (A), 
Occludin (B), Vinculin (C), and ZO-1 (D). None of the candidate adhesion proteins tested co-
immunoprecipitated with Apxl, although Apxl was visible in control blots (E). Arrows indicate β-catenin, 
Occludin, Vinculin, ZO-1, and Apxl bands, respectively. 
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4.1.2 Apxl Deletion Constructs 
To investigate the contribution of each protein domain to the localization of Apxl, a series of 
Apxl deletion constructs were generated and expressed in three mammalian cell lines (Fig. 12). 
With the assistance of Teresa Bernaciak, Apxl cDNA was cloned into the CS3mt vector, adding 
a 6X myc tag to facilitate detection of the exogenous proteins. These deletion constructs were 
initially expressed in CtBP90 cells, a fibroblast cell line which displays some epithelial 
characteristics due to mutations in ctbp1 and ctbp2 [67]. CtBP90 cells express endogenous Apxl, 
allowing comparison of endogenous and transfected Apxl by staining with anti-Apxl or anti-myc 
antibodies, respectively. When these deletion constructs were expressed in CtBP90 cells, 
proteins of the appropriate molecular weight were detectable by Western blot (Fig 12 B). All 
Apxl deletion proteins, with the exception of Apxl 1-513, were detected by both the anti-Apxl 
and anti-myc antibodies. Because the Apxl antibody was generated to amino acids 878-1287, 
Apxl 1-513 could only be detected by staining for the myc tag. 
  In order to investigate their ability to interact with actin, the full complement of Apxl 
constructs was expressed in Rat1 fibroblasts, which display an extensive actin cytoskeleton. 
Finally, Apxl deletion constructs were also expressed in MDCK cells in order to explore their 
localization to the apical junctional complex. Full-length Apxl co-localized with endogenous 
Apxl at the membranes of CtBP90 and Rat1 fibroblasts (Fig 13A). In the MDCK cell line, Apxl 
co-localized with ZO-1 at tight junctions. Additionally, Apxl staining of CtBP90 cells revealed 
localization to several focal adhesion-like structures. 
 A construct possessing only the first 513 amino acids of Apxl does not localize similarly 
to full-length Apxl. Apxl 1-513 localized weakly to tight junctions in MDCKs and was found in 
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the cytoplasm of Rat1 and CtBP90 cells (Fig 13B). Despite the inclusion of the PDZ domain, this 
N-terminal portion of Apxl does not act as the localization domain in these cell lines.  
Apxl 1-880, containing both the PDZ and ASD1 domains, displayed very strong 
membrane localization in the fibroblast cell lines, similar to the localization displayed by the 
full-length construct as well as endogenous Apxl (Fig. 13C). Apxl 1-880 also exhibited tight 
junction localization in the MDCK cell line.   
Apxl 513-880, containing only the ASD1, domain failed to localize at the membrane in 
CtBP90 and MDCK cells (Fig. 13D). Apxl 513-880 was detected in the cytoplasm in CtBP90 
and MDCK cells, although it localized to the membrane of Rat1 cells. Similarly, Apxl 513-1479, 
which possesses both the ASD1 and ASD2 domains, localized to the membrane of CtBP90 and 
Rat1 cells, while remaining cytoplasmic in the MDCK cell line (Fig. 13E). Finally, a C-terminal 
expression construct containing only the ASD2 domain, Apxl 880-1479, failed to localize to the 
membrane or junctional complexes in all three cell lines tested (Fig. 13F). Figure 16 summarizes 
the sub-cellular localization of all Apxl deletion constructs in the cell lines tested. 
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Figure 12: Apxl deletion constructs 
(A) A series of Apxl deletion constructs were generated in order to explore the contribution of each protein domain      
to Apxl localization. Apxl 1-513 was not detectable with the Apxl antibody, but endogenous Apxl was detected (red 
arrows in A) Green bar represents region used to generate Apxl antibody. (B) Deletion constructs were expressed in 
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CtBP90 cells and analyzed by Western blotting. Proteins of the correct size were detected on blots probed with 
antibodies which recognized Apxl (top panel) or the 6X –myc tag (bottom panel) FL1, Fl2 are full-length version of 
Apxl. CS3mt represents the empty myc-tagged vector. 
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Figure 13: Localization of Apxl truncation proteins varies with cell type 
Full-length (A) and truncated Apxl proteins (B-F) were expressed in CtBP90, Rat1, and MDCK cell lines 
and the subcellular localization of Apxl was observed. CtBP90 cells were stained with antibodies to Apxl 
(green) and the myc epitope tag (red) in order to compare transfected and endogenous Apxl protein. Rat1 
fibroblasts expressing Apxl deletion constructs were stained to detect Apxl (green) and actin (red). MDCK 
cells were stained with Apxl (red) and the tight junction marker ZO-1 (green) to view Apxl targeting to 
tight junctions. 
 
4.1.3 Apxl binds actin but does not cause apical constriction 
Because Apxl consistently localizes with the actin population in multiple cell types, we 
examined whether the actin cytoskeleton positions Apxl. When cells are treated with 
Cytochalasin D the actin cytoskeleton collapses. Additionally, actin-binding proteins which 
depend on actin for proper localization become mislocalized, while other proteins such as 
Vimentin and the neural recognition molecule L1 retain normal localization [68, 69]. Mouse 
cells (CtBP90) were treated with Cytochalasin D to block actin polymerization, resulting in a 
collapse of the actin cytoskeleton. After 20 minutes, the distribution of Apxl collapsed along 
with the actin cytoskeleton (Fig. 14).  This dependence on the actin cytoskeleton for proper 
localization suggests that Apxl localization is dependent on F-actin and that Apxl resides in a 
complex with actin.  
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Apxl 
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Apxl 
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Figure 14: Apxl localization collapses after cytochalasin treatment 
Cells expressing Apxl were stained to detect Apxl (green) and F-actin (red). In untreated cells Apxl 
localizes with cortical actin at the cell membrane (A). After cytochalasin treatment to breakdown F-actin, 
Apxl loses its membrane localization (B) but remains associated with actin, suggesting that Apxl associates 
with F-actin. 
 
Previous research has determined that the ASD1 domain of Shroom directly binds F-actin 
filaments, and recent work has shown that the ASD1 of Apxl can bind actin as well [24, 70]. 
Because Apxl possess a similar ASD1 domain, and Apxl localization is dependent on 
cytoskeletal integrity, actin co-sedimentation experiments were performed using a GST-tagged 
portion of Apxl containing the ASD1 domain (amino acids 513-880). GST-Apxl 513-880 was 
incubated with F-actin for one hour at room temperature. F-actin was pelleted by centrifugation 
at 100,000 X g.  GST-Apxl 513-880 remained in the soluble fraction in the absence of actin [70]. 
However, when F-actin is added to the assay, GST-Apxl 513-880 co-sediments in the fraction 
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[70]. The presence of Apxl in the pellet fraction of the co-sedimentation experiment shows that 
the Apxl ASD1 domain is capable of directly binding F- actin. 
Although Apxl and Shrm have highly similar ASD1 domains which are capable of 
binding F-actin in co-sedimentation experiments, these proteins appear to interact differently 
with actin in vivo (Fig. 15). When Rat1 cells, transfected with Apxl or Shrm, are stained for 
Shrm and F-actin, Shrm can be seen localizing to actin stress fibers (Fig. 15 A). However, Apxl 
only binds cortical actin and is not observed on stress fibers (Fig. 15 B).  
 
Shrm    
Actin A B
Apxl 
Actin 
 
Figure 15: Apxl localizes to cortical actin but not to stress fibers 
Although the ASD1 domains of Apxl and Shrm bind F-actin in cosedimentation experiments, they appear 
to interact differently with F-actin in vivo. Rat1 cells were transfected and stained for Apxl or Shrm. Shrm 
prominently stains actin stress fibers in Rat1 fibroblasts (A), while Apxl localization is limited to cortical 
actin (B). 
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4.2 DISCUSSION 
Investigation of the subcelluar localization of Apxl reveals that Apxl resides at the plasma 
membrane of sub-confluent cells and in the plasma membrane of polarized cells, possibly 
through interactions with cortical actin or members of the apical junctional complex. The high 
degree of co-localization between Apxl and ZO-1 at the apical/lateral border suggests Apxl is 
recruited to tight junctions. However, Apxl recruitment to TJs is not complete in MDCK cells, 
and significant amounts of Apxl remain in the cytoplasm, possibly due to over-expression of 
Apxl in these cells (Fig 12). Another possibility is that there is a specific mechanism for 
recruiting Apxl to TJs which functions differently in MDCK cells. Overall, the subcelluar 
localization of Apxl observed in culture correlates well with the observed expression of Apxl in 
mouse embryos. Apxl consistently localizes to sites of cell-cell adhesion in neural or renal 
epithelium, as well as in a polarized endothelial cells (Fig. 6, 7). 
Many questions remain as to how Apxl is localized in cells, and binding partners for Apxl 
remain to be identified.  Immunoprecipitation experiments, which could have hinted at   the 
functional importance of Apxl, failed to detect any interaction between Apxl and candidate 
adhesion proteins.   
Analysis of Apxl deletion proteins provided more insight into how Apxl is properly 
localized in the cell (Fig. 16). Although localization varied based on cell type, within all cell 
lines tested the ASD1 domain is crucial for proper localization. Both Apxl 1-513 and 880-1479, 
which lack the ASD1 domain, remain cytoplasmic in most cases. The ASD1 domain of Shrm has 
been shown to interact with F-actin, suggesting that this requirement for the ASD1 domain for 
Apxl localization is also due to an interaction with cortical actin. However, Apxl 513-880, which 
contains the ASD1 domain alone, does not localize to the plasma membrane as well as expected, 
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and it has not been shown to be sufficient for proper membrane/tight junction localization. Apxl 
513-880 only maintained membrane localization in Rat1 cells, suggesting that other protein 
domains contribute to Apxl localization in vivo. Alternatively, it is possible that Apxl 513-880 
does not localize to the membrane because this fragment fails to fold correctly in some contexts. 
Interestingly, it appeared that Apxl 1-880 displayed more intense membrane/tight 
junction localization than the full-length protein. This suggests that the ASD2 domain may act as 
a negative regulator of Apxl localization and, possibly, function. Finally, the contribution of the 
N-terminal PDZ domain for proper localization remains ambiguous. The PDZ domain appears to 
be irrelevant for normal Shrm localization and function. Although Apxl 513-1479 localizes to the 
plasma membrane in fibroblasts, it remains primarily cytoplasmic in MDCK cells. In contrast to 
Shrm, the Apxl PDZ domain contributes to localization in MDCK cells, either by binding to 
other proteins at the AJC or by influencing protein stability and conformation.  
 
 
Figure 16: Summary of Apxl localization 
The subcellular localization of FL and truncated Apxl constructs varies in the different cell types tested. Constructs 
lacking the ASD1 domain do not localize correctly in most cases, suggesting that this region of the protein plays a 
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crucial role in localization. The failure of Apxl 513-880 to localize to correctly in CtBP90 and MDCK cells suggests 
that this region ASD1 is required but not sufficient for proper localization.   
 
 
Although much remains to be determined about how Apxl is correctly localized, it is 
clear that proper distribution of Apxl depends, at least in part, on the ability of Apxl to bind F-
actin through its ASD1 domain. Cytochalasin D treatments have shown that disrupting the actin 
cytoskeleton perturbs Apxl localization, and actin sedimentation experiments have shown that 
Apxl binds F-actin directly. However, the observation that Apxl is capable of binding actin raises 
additional questions as to how Apxl and Shrm differ in the interactions with F-actin. Apxl and 
Shrm share three conserved domains, yet Shrm prominently decorates stress fibers while Apxl 
cannot.  A possible explanation for the differential localization patterns of Apxl and Shrm is that 
these proteins bind distinct adaptor proteins that help facilitate interactions with F-actin.  
Identification of binding partners for both Apxl and Shrm would help to explain how these 
proteins interact with actin. However, the question of how proteins localize to specific 
populations of F-actin is a fundamental question asked of many actin-binding proteins.   
Furthermore, the Shroom and Apxl differ in their ability of cause apical constriction. 
Shroom has been shown to cause apical constriction in naïve Xenopus epithelial cells as well as 
in MDCK cells [23, 39]. This constriction of the apical surface is dependent Shrm’s ability to 
interact with cortical actin.  Despite sharing Shrm’s ability to bind actin, Apxl is not competent 
to induce apical constrictions in MDCK cells [70]. This could be due to an inherent inability to 
induce constriction, or to differences in how Shrm and Apxl interact with F-actin. However, 
recent research utilizing chimeric Shrm proteins has shown that the Apxl ASD2, when placed in 
the context of Shrm, can induce apical constriction in MDCK cells [30]. Therefore, it is possible 
that the inability of Apxl to induce apical constriction is related to its mechanism of interaction 
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with actin. In support of this hypothesis, additional work from the Hildebrand lab has shown a 
correlation between actin bundling by Shrm chimeras and the ability to induce apical 
constriction. 
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5.0  SUMMARY AND CONCLUSIONS 
Western blot and immunofluorescence analysis reveal that Apxl is expressed in numerous tissues 
throughout the developing mouse, including the neural epithelium, vasculature, kidney, and 
intestine. In the adult and embryonic mice, Apxl expression seems to be limited to polarized 
epithelial and endothelial cells, where it resides at or near the apical membrane and junctional 
complexes. Regions of Apxl expression show a high degree of overlap with Shrm’s expression 
pattern, suggesting the possibility that Shrm and Apxl may function in some of the same 
morphogenetic and cellular processes. 
At the subcellular level, Apxl resides at the plasma membrane of non-adherent cells and 
in the apical compartment of polarized cells. Apxl may be recruited to these sites through 
interactions with cortical actin or members of the apical junctional complex. Overall, the 
subcelluar localization pattern observed in culture correlates well with the observed expression 
of Apxl in mouse embryos. Cytochalasin D treatments and F-actin cosedimentation experiments 
(performed by Frank Vendetti) have indicated that Apxl binds F-actin through its ASD1 domain. 
Although additional binding partners of Apxl have not been identified, Apxl consistently 
localizes sites of cell adhesion in neural or renal epithelium, as well as in a polarized endothelial 
cell line.  
Analysis of Apxl deletion constructs has shown that the actin-binding ASD1 domain is 
crucial for proper localization and that the ASD2 domain may act as a negative regulator of Apxl 
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localization. However, the requirement for the N-terminal PDZ domain  for Apxl localization 
and function remains ambiguous. Although the biological function of Apxl is unknown, its 
expression pattern, subcellular localization, and similarity to Shroom suggest that Apxl may play 
a role in regulating cellular architecture throughout development.   
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